News

New research uncovers molecular ‘safety switch’ shielding cancers from immune attack

Promising target improves antitumour response in preclinical models of pancreatic cancer

Anti-diabetic drugs and their surprising impact on cancer progression

Can community awareness campaigns in low-resource areas improve early diagnosis of colorectal cancer?

Genomic test helps flag early aggressive prostate cancer in African American patients

FDA approves amivantamab and hyaluronidase-lpuj for subcutaneous injection

New software sheds light on cancer’s hidden genetic networks

Can community awareness campaigns in low-resource areas improve early diagnosis of colorectal cancer?

New research uncovers molecular ‘safety switch’ shielding cancers from immune attack

FDA approves fam-trastuzumab deruxtecan-nxki with pertuzumab for unresectable or metastatic HER2-positive breast cancer

New study finds more comfortable option for guiding breast cancer surgery

Researchers build patient-specific models to guide complex pelvic cancer surgeries